Articles for tag: cardimyopathy, clozapine, coroner, death, diagnostics, duty of care, guidance, guidelines, heart, pfd, psychiatry, risk, treatment-resistant schizophrenia

Clozapine-Associated Cardiac Pathologies

Clozapine, an atypical antipsychotic medication, is widely recognised as the most effective treatment for individuals with treatment-resistant schizophrenia (TRS).1 Approved in 1989, its utilisation has grown, particularly for patients who have not responded adequately to other antipsychotic agents.3 Despite its superior therapeutic efficacy, clozapine carries a significant cautionary “black box warning” due to its association with rare but serious adverse effects, most notably agranulocytosis, but also considerable cardiovascular risks.5 It is important to note that, despite these risks, population-level studies ...

Schizophrenia and TRS

Schizophrenia is a widely understood and misunderstood mental health condition. Many mental health professionals believe they ‘know’ what schizophrenia is. Ideas ‘about delusions and hallucinations’ just scratch the surface, as will be seen when ICD-11 criteria are explored. Millions of pages of journals and books have been written on this topic over the last 30 years. This article could not possibly condense all the important aspects of schizophrenia to everyone’s satisfaction. Between higher specialist training and into the first 5 ...